Skip to Main content Skip to Navigation
Journal articles

STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS)

Abstract : Abstract Stimulator of interferon genes (STING) contributes to immune responses against tumors and may control viral infection including SARS-CoV-2 infection. However, activation of the STING pathway by airway silica or smoke exposure leads to cell death, self-dsDNA release, and STING/type I IFN dependent acute lung inflammation/ARDS. The inflammatory response induced by a synthetic non-nucleotide-based diABZI STING agonist, in comparison to the natural cyclic dinucleotide cGAMP, is unknown. A low dose of diABZI (1 µg by endotracheal route for 3 consecutive days) triggered an acute neutrophilic inflammation, disruption of the respiratory barrier, DNA release with NET formation, PANoptosis cell death, and inflammatory cytokines with type I IFN dependent acute lung inflammation. Downstream upregulation of DNA sensors including cGAS, DDX41, IFI204, as well as NLRP3 and AIM2 inflammasomes, suggested a secondary inflammatory response to dsDNA as a danger signal. DNase I treatment, inhibition of NET formation together with an investigation in gene-deficient mice highlighted extracellular DNA and TLR9, but not cGAS, as central to diABZI-induced neutrophilic response. Therefore, activation of acute cell death with DNA release may lead to ARDS which may be modeled by diABZI. These results show that airway targeting by STING activator as a therapeutic strategy for infection may enhance lung inflammation with severe ARDS.
Document type :
Journal articles
Complete list of metadata
Contributor : SCD Université d'Orléans Connect in order to contact the contributor
Submitted on : Tuesday, September 6, 2022 - 10:07:47 AM
Last modification on : Wednesday, September 7, 2022 - 3:07:09 AM

Links full text




Yasmine Messaoud-Nacer, Elodie Culerier, Stéphanie Rose, Isabelle Maillet, Nathalie Rouxel, et al.. STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS). Cell Death and Disease, Nature Publishing Group, 2022, 13 (3), pp.269. ⟨10.1038/s41419-022-04664-5⟩. ⟨hal-03770070⟩



Record views